Studies in ethics, law, and technology最新文献_第4页

For Me to Know and You to Find Out? Participatory Mechanisms, The Aarhus Convention and New Technologies 让我知道，让你发现?参与机制、《奥胡斯公约》和新技术

Studies in ethics, law, and technology Pub Date : 2010-09-29 DOI: 10.2202/1941-6008.1125

J. D'Silva, Geert van Calster

引用次数: 5

The Ethical Significance of Expectations and the Case of Microsoft Office Accounting 期望的伦理意义与Microsoft Office会计案例

Studies in ethics, law, and technology Pub Date : 2010-08-19 DOI: 10.2202/1941-6008.1128

Thomas Ploug

引用次数: 4

Regulation and Safety Assessment of Genetically Engineered Food 基因工程食品的规管及安全评估

Studies in ethics, law, and technology Pub Date : 2010-02-10 DOI: 10.2202/1941-6008.1100

O. Singh

引用次数: 3

Ethics of Human Enhancement: 25 Questions & Answers 人类发展的伦理:25个问题与答案

Studies in ethics, law, and technology Pub Date : 2010-02-10 DOI: 10.2202/1941-6008.1110

Fritz Allhoff, Patrick Lin, J. Moor, J. Weckert

引用次数: 89

Natural versus Assisted Reproduction: In Search of Fairness 自然与辅助生殖:寻求公平

Studies in ethics, law, and technology Pub Date : 2010-02-10 DOI: 10.2202/1941-6008.1109

D. Cutas, L. Bortolotti

引用次数: 7

Can Scientists Regulate the Publication of Dual Use Research? 科学家能否规范军民两用研究成果的发表?

Studies in ethics, law, and technology Pub Date : 2010-02-01 DOI: 10.2202/1941-6008.1124

David B Resnik

引用次数: 23

Avoiding the Mistakes of Biotech: How Intellectual Property Can Be Better Managed to Advance Nanotechnology Research 避免生物技术的错误:如何更好地管理知识产权以推进纳米技术研究

Studies in ethics, law, and technology Pub Date : 2010-01-26 DOI: 10.2202/1941-6008.1114

R. Gold

引用次数: 3

International Harmonization of Regulation of Nanomedicine 国际纳米医学监管协调

Studies in ethics, law, and technology Pub Date : 2010-01-26 DOI: 10.2202/1941-6008.1120

G. Marchant, Douglas J. Sylvester, Kenneth W. Abbott, T. Danforth

{"title":"International Harmonization of Regulation of Nanomedicine","authors":"G. Marchant, Douglas J. Sylvester, Kenneth W. Abbott, T. Danforth","doi":"10.2202/1941-6008.1120","DOIUrl":"https://doi.org/10.2202/1941-6008.1120","url":null,"abstract":"Nanomedicine holds enormous promise for the improved prevention, detection and treatment of disease. Yet, at the same time, countervailing concerns about the potential safety risks of nano-technologies generally, and nanomedical products specifically, threaten to derail or at least delay the introduction and commercial viability of many nanomedicine applications. All around the globe, national governments are struggling with balancing these competing benefits and risks of nanotechnology in the medical and other sectors. It is becoming increasingly clear that reasonable, effective and predictable regulatory structures will be critical to the successful implementation of nanotechnology. The question examined in this paper is whether there are mechanisms of international harmonization or cooperation that can facilitate the development of more effective and efficient regulatory regimes for nanomedicine?Part I of this paper briefly summarizes the promise of nanomedicine as well as potential concerns about the risks of nanomedical applications that will require regulatory oversight. In Part II, we analyze the various factors weighing for and against attempts to harmonize regulatory requirements at the international level. Finally, in Part III we identify some specific existing or feasible mechanisms that may be useful for fostering international harmonization in the regulation of nanomedicine.","PeriodicalId":88318,"journal":{"name":"Studies in ethics, law, and technology","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2010-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2202/1941-6008.1120","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68799584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 20

Nanotechnologies and Equal Access to Healthcare 纳米技术与平等获得医疗保健

Studies in ethics, law, and technology Pub Date : 2010-01-26 DOI: 10.2202/1941-6008.1116

S. Arnaldi, M. Piccinni

引用次数: 2

The Principle of Justice and Access to Nanomedicine in National Healthcare Systems 司法原则和获得纳米医学在国家卫生保健系统

Studies in ethics, law, and technology Pub Date : 2010-01-26 DOI: 10.2202/1941-6008.1121

M. Ebbesen

{"title":"The Principle of Justice and Access to Nanomedicine in National Healthcare Systems","authors":"M. Ebbesen","doi":"10.2202/1941-6008.1121","DOIUrl":"https://doi.org/10.2202/1941-6008.1121","url":null,"abstract":"The focus of this article is fair access to nanomedicine, which refers to the application of nanotechnology to medicine. By use of nanotechnology improved diagnostics and therapy are expected in medicine and health care. Researchers, however, warn that nanomedicine products may be so expensive when they go on the market that they may provisionally make health inequalities worse both nationally and internationally. If this is true, it raises specific questions of justice as to whether we should accept these inequalities and accept that some persons may not have access to health care.This article argues that a promising approach to the ethics of nanomedicine is given with the ethics of the American ethicists Tom L. Beauchamp & James F. Childress. The article introduces the basic ethical principles of these authors: respect for autonomy, beneficence, nonmaleficence, and justice. Specific attention is dedicated to the principle of justice and fair access to national health care. The principle of justice of Beauchamp & Childress is discussed and with the aim of creating fair access to nanomedicine, this article suggests an appropriate principle of justice to evaluate this field.Accordingly, this article defends a national health care system based on an egalitarian principle of justice, which requires equal access to health care including long-term and chronic care services. Also, it is argued that, contrary to the suggestion by Beauchamp & Childress, persons are entitled to social coverage of health care even though they suffer from a disease caused by personal autonomous activities. If it is economically feasible, nanomedicine should be included in the national health care system and it should be accessible to all citizens.","PeriodicalId":88318,"journal":{"name":"Studies in ethics, law, and technology","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2010-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2202/1941-6008.1121","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68800019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4